Clinical Trial Update: Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Edaravone Dexborneol for acute ischemic stroke treated with endovascular therapy in extended time windows.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Ischemic

Drugs mentioned

• Edaravone Dexborneol

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Stroke, Ischemic | Phase 2 | Status: UNKNOWN